 Kala Pharmaceuticals Inc KALA shares are trading higher Thursday. The stock appears to be moving on continued momentum after the company on Wednesday announced FDA acceptance of an investigational new drug IND application for KPI-012 for the treatment of persistent corneal epithelial defect. 